| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Verve Therapeutics We are on a mission to protect the world from cardiovascular disease. Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially … Type: | 13 | 0 | 9 | 295 |
 |  Pathwaves - Supermind Your Path to Better Brainwaves Pathwaves has become Supermind. Creator of Neural EmpowermentTM a proprietary, multi-dimensional and innovative methodology that uses the powerful principles of neuroplasticity along with integrative biofeedback and timeless healing modalities to help people attain an optimal state of mental, emotional, spiritual, and physical harmony. As a for-profit, social impact company, Pathwaves was established in 2016 with eight years of research and development preceding its launch. The Pathwaves team uses advanced technology to provide clients the tools to re-parent their cells utilizing their Brainwave Positioning SystemTM(BPS) – customized for each individual’s genetics, current biology, beliefs, life experiences, … Type: | 0 | 0 | 0 | 2 |
 | THREAD DCT Leader in Everest Group's PEAK Matrix® & Positioned in Leader’s Category for R&D DCT Technology Solutions by IDC THREAD is a leading provider of a proprietary, decentralized research platform and suite of supporting services used by biopharma, CROs and life science organizations to remotely capture data from participants and sites during, in-between and in lieu of in-clinic visits. THREAD's platform and supporting services are helping customers to reduce study launch timelines, reduce study budgets with Virtual Visits and bring studies from the clinic to patients' homes. THREAD provides key platform features such as eConsent, eCOA/ePRO, sensors, reminders and telehealth … Type: | 18 | 0 | 15 | 109 |
 | Nutrigene Our mission is to optimize health and prevent nutrition-related disease, which affects over half of the world’s population. Current supplement solutions are ineffective and inconvenient. Dried pills lack potency while liquid vitamins quickly degrade - neither form gives your body specifically what it needs to perform. Nutrigene helps you optimize your health - by sending you pure, personalized liquid supplements. Pick a goal, fill out our metabolic assessment, and we will optimize your supplements based on scientific research to create unique formulations are 10x more effective than generic off the shelf pill-based formulations. Type: | 1 | 0 | 1 | 1 |
 | AUM Biosciences Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules Type: | 2 | 1 | 1 | 18 |
 | Unicorn Biotechnologies Automated, modular, scalable biomanufacturing We industrialize cell culture. Unicorn is building machines to standardize, automate, and scale cell culture processes and manufacturing workflows, starting with iPSCs. Our goal is to enable better research, faster translation to products and therapeutic candidates, and to remove the barriers to scaled manufacture. So that we can help create a more sustainable future on planet Earth, where all people live healthier, longer lives. Type: | 3 | 1 | 3 | 14 |
 | Arctoris Arctoris is a tech-enabled Contract Research Organization (CRO) headquartered in Oxford, UK. Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered in Oxford. We combine our unique automation platform, Ulysses, with a world-class team of excellent laboratory scientists to guide and rapidly progress our partners’ drug discovery programs from target to candidate. Data is the lifeblood of research, and “Better Data leads to Better Decisions”. Our excellent service is built on: 1) Data quality: generating large reproducible datasets by leveraging robotics and wet lab automation, in turn empowering improved decision-making. 2) Our world-class team of experienced scientists: a true partner … Type: | 9 | 1 | 8 | 38 |
 | Biotalys Transforming crop protection We are an agricultural technology (agtech) company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of crop protection products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols aim to combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are on track to have … Type: | 10 | 4 | 8 | 68 |
 | RefleXion Medical SCINTIX biology-guided radiotherapy is now FDA cleared. SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease. cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering Type: | 3 | 3 | 1 | 258 |
 | Inspirna, Inc. Converting cancer to a manageable, chronic condition Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE … Type: | 3 | 2 | 1 | 34 |
 |  Artios Taking control of the DNA Damage Response (DDR) Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. … Type: | 8 | 3 | 1 | 127 |
 | Chromologics Natural Colors Crafted By Fermentation Chromologics is a Danish biotech start-up responding to the strong market pull for novel natural food colorants. We develop fungal fermentation solutions for the production of natural pigments. Our proprietary production process allows not only for a more sustainable production than existing solutions, but is also cost-competitive. Our pigments are produced by a non-GMO fungus, which makes them compliant with the dietary requirements of broad consumer bases such as kosher, halal, and vegan diets. Fermentation, Natural Colorants, University Spin-Out, Downstream Processing, and Color formulation Type: | 5 | 1 | 3 | 25 |
 | MOBILion Systems, Inc. The MOBILion team is focused on developing instruments that improve how we predict, diagnose and treat disease. MOBILion’s technology makes it easy to separate, identify and analyze the most challenging molecules that other instruments fail to detect. Our higher resolution, faster analysis and simpler workflows reveal molecules that are most important in characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests. We make today’s treatment’s safer and more effective, empower tomorrow’s disease prediction and diagnosis, and accelerate the development of new therapies. Type: | 3 | 1 | 2 | 58 |
 | ProQR Therapeutics Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing Type: | 4 | 3 | 1 | 179 |
 | Regenosine Harnessing the healing potential of adenosine for tissue regeneration Privately held company focused on developing and marketing first-in-class regenerative therapies for osteoarthritis. Our proprietary platform technology harnesses the healing potential of the purinergic system which plays a critical role in maintaining cartilage homeostasis. Our lead product is a proprietary formulation for regenerating cartilage in joints with established osteoarthritis, targeting a rapidly growing joint preservation market. Our goal is to offer patients a disease modifying therapy with uncompromising efficacy relative to existing technologies. By developing this disease modifying therapy, we will significantly improve clinical outcomes and patient quality of life, and … Type: | 0 | 0 | 0 | 2 |
 | Phasya (acquired by Tobii) Phasya has been acquired by Tobii. Phasya is now a part of Tobii, the world leader in eye tracking and a pioneer in attention computing. Our combined expertise and decades of experience enable us to deliver disruptive solutions to the automotive industry and others. Visit tobii.com to find out more about Tobii's mission software development, eye tracking, image processing, engineering, signal processing, drowsiness detection, human factors, neurology, safety, cognitive load, stress, FRMS, and Fatigue Risk Management Type: | 5 | 1 | 4 | 1 |
 | Dolphin Vision We print air We make the air healthy through the decarbonization and destruction of viruses. Dolphin Vision creates CO2-free and virus-free zone solutions for Public spaces, offices, hubs, and Public transportation. Type: | 2 | 0 | 2 | 5 |
 | BiogeniQ BiogeniQ helps people optimize their nutrition and medication based on their genetic composition. We allow everyone to access important portions of their DNA, while providing a useful tool for healthcare professionals. We put emphasis on solid, peer-reviewed research and integration of our genetic reports into future healthcare. Médecine Personnalisée, Dépistage Génétique, Nutrigénomique, Pharmacogénétique, Génotypage, and Génomique | 5 | 3 | 4 | 2 |
 | Logisens | 0 | 0 | 0 | 7 |
 | Dianomi Therapeutics | 0 | 0 | 0 | 7 |
 |  Covagen AG Covagen AG is a biotechnology company based out of Switzerland. | 0 | 0 | 0 | 2 |
 | Allcyte | 2 | 2 | 1 | 13 |
 | Imagia Canexia Health Closing the health-equity gap in cancer. Imagia Canexia Health (ICH) is a genomics-based cancer treatment testing company that accelerates access to precision care by combining AI expertise with advanced molecular biopsy solutions. Leveraging AI-based informatics for treatment selection and monitoring, oncologists now have leading clinical decision support right at their fingertips. With a network of over 20 hospitals and reference labs worldwide, ICH ensures that doctors have the right insights to deliver cost-effective cancer testing to patients no matter where they seek treatment. Type: | 20 | 1 | 11 | 7 |
 | Beacon Biosignals Our mission is to improve human health by enabling rapid, targeted interventions through advanced brain analytics. Beacon's AI platform for brain data enables and accelerates new treatments that transform the lives of patients with neurological and psychiatric disease. Through FDA-cleared EEG wearables, novel machine learning algorithms, enormous datasets, and advances in software engineering, we are changing the way patients are treated for disorders of the brain. Type: | 23 | 10 | 8 | 78 |
 | CAERvest Type: | 2 | 1 | 1 | 0 |
 | ConquerX Type: | 2 | 0 | 2 | 3 |
 | CamBioScience Type: | 8 | 1 | 4 | 11 |
 | ATLANCHIM PHARMA BUILDING MOLECULES FROM IDEAS ATLANCHIM PHARMA is a chemistry-based CRO (Contract Research Organization) conducting confidential custom synthesis of complex molecules tailored to customer specifications. Our team provides multi-step organic synthesis from a milligram to several gram scale. CRO, Custom synthesis, Chemistry, Research & Development, Organic chemistry, Medicinal chemistry, Reproduction services, Stable isotope labeling, Organic synthesis, Heterocycle synthesis, Carbohydrate chemistry, Peptide synthesis, Impurety synthesis, and Hit to lead Type: | 3 | 1 | 3 | 12 |
 | GTP Bioways Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market GTP Bioways is an expert and fast-growing contract development and manufacturing organisation (CDMO) offering uniquely customised process development and manufacturing services for biologics, antibody-drug conjugates and nanodrugs. With cutting-edge facilities located in France, GTP Bioways supports biopharma companies in bringing their innovative molecules from research to clinic and market. Biologics, Nanodrugs, Process Development, Analytics, Biopharmaceuticals, and GMP Manufacturing Type: | 21 | 5 | 20 | 149 |
 | APC Europe Global Leader in Functional Proteins - Helping Animals Thrive 📣 Who is APC Europe? We are the world’s largest manufacturer of Spray-Dried Plasma, Hydrolyzed Proteins and other High-Quality Proteins. Our main goal is researching and producing feed ingredients with the best quality to enhance health and animal nutrition. APC Europe is part of the LGI Group and subsidiary of APC Inc. -Ankeny (Iowa). 🔧 What APC Europe does? At APC, we market, research and develop products principally derived from blood proteins based on customer need. We efficiently procure and manufacture safe and effective products for use in animal, with a … Type: | 2 | 1 | 1 | 67 |
 | Kinoxis Therapeutics Pty Ltd Kinoxis Therapeutics is a private, Australian-based, clinical stage biotechnology company developing first-in-class therapeutics to address the escalating demand for effective treatments for substance use disorders and social dysfunction in neurological and psychiatric disorders. Kinoxis’ development candidates are novel, small molecules that were discovered through a comprehensive medicinal chemistry and screening program at the University of Sydney. Kinoxis is backed by Uniseed, Australia’s longest running venture fund, and a consortium of sophisticated investors, and secured funding from the US National Institutes of Health National Institute on Drug Abuse for the development of its lead compound to mitigate opioid withdrawal symptoms. Kinoxis’ … Type: | 1 | 1 | 1 | 16 |
 | The Livestrong Foundation Which everyday cancer problem will we fix today? Livestrong is dedicated to disruptive, energetic and breakthrough ideas designed to ensure that each and every cancer patient doesn’t just survive, they Livestrong. Known for its powerful brand, Livestrong has become a symbol of hope and inspiration around the world. Since its inception, the Foundation has served 11 million people affected by cancer. cancer care, cancer support, cancer advocacy, and global health Type: | 9 | 3 | 3 | 64 |
 | Engsolve Limited Full project life cycle engineering services from Energy from Waste to Emerging Tech, we've got you covered! #engsolveit Engsolve is a multi-disciplined engineering consultancy with significant experience in undertaking engineering design and support, cost estimating and control, project management and safety risk assessments across many industries including chemical, energy- from-waste, high volume manufacturing, paper, pharmaceuticals, construction and operating facilities. The principals of Engsolve have, collectively, over 50 years of process design, engineering, operations, facilities management, HSE management and cost and project management experience. All of our engineers hold Chartered Engineer status with their relevant Institutions, and have provided high quality … Type: | 1 | 1 | 1 | 14 |
 | Theralase Technologies (TSXV: TLT) Destroying cancer at the speed of light Theralase® Technologies is a Canadian clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers. We strive to continuously improve the quality of life for those afflicted with cancer by focusing our research and development on preventing, alleviating and treating diseases. Serving our higher purpose to bring hope for cancer treatments to light. Founded in 1994, Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the … Type: | 1 | 1 | 0 | 34 |
 | Pistoia Alliance Where life science collaborates. We are a global, not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D. Our projects transform R&D innovation through pre-competitive collaboration. We bring together the key constituents to identify the root causes that lead to R&D inefficiencies. We develop best practices and technology pilots to overcome common obstacles. Our members collaborate as equals on open projects that generate significant value for the worldwide life sciences community. research and development, life science, healthcare, biopharma, and R&D Type: | 32 | 3 | 30 | 44 |
 | Kuraray Kuraray was founded in 1926 for the purpose of commercializing synthetic rayon, a cutting-edge technology at that time. The Company has continued to expand since then, keeping a focus on fibers and textiles. In 1950, shortly after World WarII, Kuraray was the first in the world to commercialize PVA fiber. It was the first synthetic fiber made in Japan and led the early phase of Japan’s synthetic fiber industry. Since then, Kuraray has continued to expand in the chemical industry based on the proprietary polymer and synthetic chemistry technologies it developed in fibers. Today, the Company operates globally in 31 … Type: | 7 | 2 | 0 | 2,506 |
 | SCbio Building the business of life sciences in South Carolina A statewide, not-for-profit, public/private life sciences industry association and economic development organization formed to actively promote, build, support, expand, and convene South Carolina's life sciences industry. Official state affiliate of BIO -- the U.S. Biotechnology Innovation Organization -- and the exclusively dedicated advocate and 'voice' for the multi-faceted SC life sciences industry. BIO champions biotechnology and its potential to provide better healthcare, enhanced agriculture, and a cleaner and safer environment for people around the world. SCbio is powered by a dynamic portfolio of public/private members and stakeholders, and is a primary … Type: | 6 | 0 | 6 | 21 |
 | DKMS Deutschland [Automatic translation follows] We defeat blood cancer! The DKMS is an international non-profit organization dedicated to the fight against blood cancer. It was founded in Germany in 1991 by Dr. Peter Harf and since then, with over 1,300 employees, has pursued the goal of giving as many people as possible a second chance at life. To date, it has succeeded in doing this more than 115,000 times with over 12 million registered life donors by arranging stem cell donations. This makes it the world leader in the care of patients with stem cell transplants. In addition to Germany, the organization … Type: | 6 | 4 | 2 | 244 |
 | UroMems UroMems is a biotechnology company based out of 5, rue Raymond Chanas, 38320, Eybens, FRANCE Urologie and Dispositifs médicaux Type: | 13 | 2 | 0 | 63 |
 | BIOBank S.A. L'os humain préservé et régénéré BIOBank is a leader providing high-quality bone allografts to surgeons in orthopaedics, maxillofacial, and dental surgery. Our bone grafts are sourced from living donors in France & processed via our perfected Supercrit® technology, providing key advantages to surgeons and patients: - Total viral-inactivation - Maintainance of biomechanical and structural intergrity of the tissue - Availability in various shapes & forms, allowing easy handling during the surgical procedure - High quality bone integration, improving patient recovery BIOBank assure l’ensemble des activités d’une banque de tissus, de la prise en charge des tissus (recueil) à la délivrance … Type: | 1 | 1 | 0 | 39 |
 | Fitabeo Therapeutics Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology Type: | 0 | 0 | 0 | 5 |
 | Genewity B.V. Genewity is a pioneering biotech start-up focused on advanced thymus-driven therapies for immune reconstitution. Supported by the extensive business expertise of our management and advisors, we are at the forefront of developing and commercialising breakthrough therapies. With over 150 years of combined experience in immunology and gene therapy, our team is uniquely positioned to drive advancements in the field. Type: | 0 | 0 | 0 | 15 |
 | Hooke Bio Ltd. Biotech Startup who have developed a fully integrated high throughput screening system for 3D microtissues Hooke Bio Ltd. was founded in 2014 by Professor Mark Davies at Stokes Laboratories, University of Limerick (UL), a research center which has a rich history of microfluidic entrepreneurship. Hooke Bio spun out from the UL in 2017 and is currently based in Shannon, Co. Clare, Ireland. The company is named after Robert Hooke (scientist, astronomer, engineer and architect). He was the first person to image a microorganism using a microscope and coined the term "cell". Prior to 2017, Hooke Bio was funded by two … Type: | 0 | 0 | 0 | 14 |
 | Haus Der Wissenschaft Haus Der Wissenschaft is a company based out of 4 Sandstr., Bremen, Bremen, Germany. | 1 | 1 | 0 | 2 |
 | Hamlet BioPharma An innovative pharmaceutical company with a broad portfolio of projects for the treatment of cancer and infections Hamlet BioPharma AB is a pharmaceutical company with strong links to research, working with natural and biological substances. The company was formed through the merger of two pharmaceutical companies, Hamlet Pharma AB and SelectImmune Pharma AB, and is listed on the Spotlight Stock Market. Hamlet BioPharma is a formidable pharmaceutical company specializing in the development of drugs for the treatment of cancer and infectious diseases. The company has a portfolio of a total of ten drug projects, three of which are in Phase … Type: | 0 | 0 | 0 | 8 |
 | Cytovation Creating transformative medicines for patients with cancer Cytovation is a clinical stage immuno-oncology biotech developing first-in-class immunotherapies. CyPep-1, its lead asset, is a synthetic peptide engineered to selectively target tumor cells. CyPep-1 has a unique dual MoA applicable across solid tumors: (1) direct tumor-specific membrane lysis and in-situ vaccination, combined with (2) immune activation through inhibition of the β-catenin pathway. Building on strong FIH clinical data, Cytovation is advancing CyPep-1 to POC/pivotal clinical development with a focus on b-catenin-driven cancers. Biotech, Oncology, and Immuno-oncology Type: | 0 | 0 | 0 | 12 |
 | General Biotechnologies | 0 | 0 | 0 | 0 |
 | Logichem Logichem is a pharmaceuticals company based out of 3 Wellesley Court, London, United Kingdom. | 3 | 2 | 2 | 10 |
 | Karveel | 0 | 0 | 0 | 0 |
 | Nano3D Biosciences Nano3D Biosciences (n3D) is a biotechnology startup located in Houston, TX focused on 3D cell culture solutions for biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine. Our core technology, magnetic 3D bioprinting, works by magnetizing cells and aggregating them with magnetic forces into models that represent native tissue environments. The advantages of this platform over other 3D cell culture and bioprinting platforms are speed, ease, and handling. n3D offers products and services around this technology, with a worldwide distribution network, including an OEM partnership with Greiner Bio-One Cell culture, Assay development, 3D cell culture, Precision medicine, Toxicology, and … Type: | 1 | 0 | 0 | 1 |
 | viomedo Even today many patients can’t effectively be treated with the standard of care. Most patients don’t want to wait many years until new therapies become available. They want to take action. They want to contribute to the medical progress. Viomedo connects patients with medical research in order to help improve existing therapies and find cures. We are the leading platform for medical research in the German speaking region. Together with researchers, patient support groups, research hospitals and pharmaceutical companies we want to transform medical research all over Europe. Viomedo - tomorrow’s medicine, today. Patient Recruitment, Clinical Trials, Internet, Innovative Treatments, … Type: | 6 | 1 | 5 | 1 |
 | StemTek Therapeutics StemTek Therapeutics is a start-up biotechnolgy company dedicated to accelerating drug discovery in cancer using cutting edge technology, world-class science and a stem cell centric point of view for cancer therapy. Our mission is to help design novel treatments for cancer targeting cancer stem cells. Type: | 1 | 0 | 1 | 1 |
 | MedAngel Bringing peace of mind to everyone who uses temperature sensitive meds (#insulin #GLP1 #biologics #hormones #humira). We are a digital health company with the mission of patient empowerment. Our product MedAngelONE helps people, who are using temperature-sensitive medications. It consists of an App which, together with a small sensor, enables users to monitor the temperature of their medications easily with their smartphone. This does not only solve a problem in their everyday life, it also covers the last mile of cold chain management and enhances medication safety. Health, Pharmaceutical, Patient Empowerment, Temperature Monitoring, and Diabetes Type: | 6 | 3 | 2 | 1 |
 | Yarok Microbio New fast testing technology for agriculture and the food industry. Results in 45 minutes not days, only real CFU. Yarok Microbio has developed a breakthrough new technology for fast detection of dangerous microbes (E.coli, Listeria, Salmonella, etc.) and of Plant Pathogens for agriculture and the entire food supply chain. The technology protects consumers, avoids product recalls, saves production costs, empowers farmers as well as large and small food producers. By slashing the time of detection and enumeration of possible presence of pathogenic microbes from days to 45 minutes, with off-the-shelf tools and on location instead of an offsite microbiological laboratory, … | 2 | 2 | 0 | 4 |
 | Nascent Biotech, Inc. Nascent’s development approach utilizes the immune system’s innate capabilities and selectivity. Nascent Biotech, Inc. (OTCMKTS:NBIO) is a public company, formed in March 2014, to continue development of Pritumumab, a human monoclonal antibody created by a number of leading scientists who have developed various monoclonal antibodies and cytokine treatments for oncology indications. Pritumumab recognizes a unique and proprietary antigen expressed on the surface of cancer cells and is being developed to treat brain and pancreatic cancers, both unmet clinical needs. NBIO’s clinical premise is that the most effective way to treat disease is to modulate (boost or suppress) the human body’s … Type: | 0 | 0 | 0 | 1 |
 | NestEgg Labs Clever Automation Made Simple NestEgg Labs is a company providing innovative lab automation tools for cell culture applications. We are developing the Ovation hardware along with software to control it remotely and sterile disposable parts. Ovation, our flagship product, is a smart incubator that automates cell culture processes and cellular assays. The combination of powerful lens-free microscopy and fluid handling reduces experimental errors and time consuming activities. The system allows for a range of workflows to be reliably automated remotely using cloud-based software. Ovation is an affordable, flexible, and fully controllable laboratory automation system that ensures a smoother workflow in … Type: | 3 | 1 | 3 | 5 |
 | Medtechy.com The place for the latest medical technology news, medical device/biotech company intel and career opportunities. Medtechy reaches over 25k medical sales professionals each month, with the latest healthcare news and insight, company discussion forums and a new job platform for recruiters and employers to reach over 25k (and growing) medical sales professionals each month. Recruiters and Employers: Stop by Medtechy Jobs and check out our new pricing, which offers two jobs for $150. All Medtechy job listings are distributed to millions of candidates through our website, social channels, email job alerts and a syndication network, which includes a targeted publisher … Type: | 0 | 0 | 0 | 1 |
 | Scaled Biolabs Inc. Working at the frontier of microfluidics, automation and machine learning to accelerate cell-based medicines. Scaled Biolabs accelerates the discovery and development of complex cell-based medicines, such as stem cell therapies and cancer immunotherapies. Their full stack optimization engine reduces complexity and time to market, by leveraging high-throughput, micro-scale cell culture, automation, and deep data insight. It also powers internal, grant funded programs such as developing a new gold standard for manufacturing dopaminergic neurons to treat Parkinson’s disease. Microfluidics, Biomedical R&D, Bioreactor, Single-cell Biology, Bioengineering, Stem Cells, Tissue Engineering, Cell Culture, Cell-based Assays, machine learning, and computer vision Type: | 0 | 0 | 0 | 1 |
 | Canomiks Making food as medicine a reality. Canomiks is a biotechnology company that is a pioneer in the future of the functional food and beverage and dietary supplement industries with its groundbreaking genomics, bioinformatics, and AI-based solutions. By offering R&D and pre-clinical solutions, Canomiks helps CPG companies, suppliers, and manufacturers test and develop scientifically backed ingredients and products. Their cutting-edge technology can innovate new formulations and validate, test, and certify the biological efficacy and safety of functional ingredients and formulations. Founded by three esteemed Harvard scientists, Canomiks leverages exclusive intellectual property to bring unparalleled transparency, truth, and trust to the natural … Type: | 3 | 1 | 3 | 5 |
 | CRB Health Tech SGEIC CRB is a Private Venture Capital Management firm specialized in Health Technologies. It was founded by a senior multi-disciplinary executive team. It has incorporated three previous Funds with focus on Biotech (Fund I), Medtech (Fund II), and Digital Health (Fund Nuubo). Currently incorporating the Fund III (CRB Digital Health III), a specialized Fund on Digital Health supported by a team with a large experience in startups, scaleups, corporates, and public health institutions. Based in Madrid and Barcelona, with access to the most innovative hubs in Europe. comunicacion@crossroadbiotech.com Lactose intolerance, Alzheimer, Wearable technologies, Cancer diagnostics, Genetic diagnostics, Nanomechanical biosensing, NASH diagnostics, … Type: | 1 | 0 | 1 | 9 |
 | Oritain Forensic science verification of origin providing traceability in supply chains. Sustainability isn’t just about tackling climate change, it represents a growing conscience around our actions and the impact they have on people, animals and planet. The personal, professional and governmental move to sustainable practice is driven by a desire to change our impact on the world, but we can’t do this without knowing the certainty of our actions. Transparency is one way of holding ourselves accountable, but for it to be effective it must be underpinned by proven traceability. Our scientific traceability does just that. Working with Mother Nature, we … Type: | 11 | 2 | 11 | 202 |
 | GlyCardial Diagnostics Act before it's too late! GlyCardial Diagnostics is a spin-off company of the Catalan Institute of Cardiovascular Sciences (ICCC) and the Spanish National Research Council (CSIC) focused on the development of a novel in vitro diagnostic device for myocardial ischemia. The technology is based on the detection of Apo J-Glyc in blood as a biomarker for the early diagnosis of cardiac ischemia and the prediction of patient’s evolution after an ischemic event. GlyCardial Diagnostics was created by scientists Lina Badimon, Judit Cubedo, Teresa Padró and Gemma Vilahur. The company is located at the Hospital de la Santa Creu i Sant … Type: | 3 | 2 | 2 | 2 |
 | MycoWorks We’re on a journey to Grow the Future of Materials. We’re on a journey to Grow the Future of Materials. How? By unlocking the unique properties of mycelium, the root structure of mushrooms. Our patented technology, Fine MyceliumTM, unleashes a new class of materials crafted from nature, engineered for performance, and built for a resilient future. Our impact on future generations steers our innovations today. From our expertise in mycology and materials science to our manufacturing innovations, we’re creating new possibilities for industry. We’re an outstanding team of scientists, engineers, product experts, artists, leaders—and you. Biomaterials, Biotechnology, Design, Composites, Sustainability, … Type: | 8 | 1 | 1 | 223 |
 | Tebubio Facilitators of Life Sciences Research We facilitate Life Sciences Research every day, contributing to advance Science for a brighter future. Through our local offices located across Europe, we support Life Sciences and Biotechnology Researchers with a unique, holistic range of solutions to advance their projects faster: - We enable researchers to be at the forefront in their Research with access to cutting-edge biological solutions sourced from reputed global Life Sciences suppliers, carefully selected by our Scientific Team for their relevance and evaluated for their ethical and legal compliance. - We accelerate their Research thanks to our Contract Research Services’ … Type: | 15 | 2 | 13 | 81 |
 | CeleScreen CeleScreen develops an innovative technology for the rapid screening of xenobiotics toxicity by means of Caenorhabditis elegans, a <1mm nematode, long-known model for human metabolism. It is a unique solution for systemic toxicity, reprotoxicity, teratogenicity, while avoiding vertebrate testing. Primary targets are in the cosmetics industry to face REACH demands. Celescreen has recently launched collaborative projects incorporating C. elegans and in silico approaches for drug development in human health. Incorporated in 2015, based at Hôpital Lariboisière in Paris, CeleScreen is a licensee of Assistance Publique - Hôpitaux de Paris (AP-HP), a major player in human health with >20,000 medical doctors. … Type: | 12 | 5 | 7 | 2 |
 | Hemerion Therapeutics A new player committed to tackle #glioblastoma and #brain #cancer Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma. Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma. Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer. Type: | 38 | 5 | 20 | 16 |
 | mySkin Inc. mySkin, Inc. is bringing to market the world's first mobile connected, personal skin coach - OKU. OKU uses visible light to measure the skin's health, compare it to "SkinTwins" - people with the same gender, age, ethnicity, etc. and offer recommendations to get our skin into its youthful best. Recently, mySkin closed a Series A with a leading global VC fund and has multiple deals with a strategic personal care franchise. Check out videos of OKU or jump straight ahead to www.getoku.com! mySkin also invented the world’s first transdermal skin analysis system (dermographTM). The dermographTM uses a new approach to … Tags: H2020 Type: | 2 | 1 | 1 | 11 |
 | Cardax, Inc. Cardax is developing orally bioavailable anti-inflammatory compounds with robust safety for major unmet medical needs. Cardax (OTCQB: CDXI) is developing proprietary astaxanthin therapies for large unmet medical needs where oxidative stress and inflammation play important causative roles. Introduction Cardax is a development stage life sciences company that devotes substantially all of its efforts to developing nutraceutical and pharmaceutical products that provide the anti-inflammatory benefits of steroids or NSAIDS, but with exceptional safety profiles, as conferred by U.S. Food and Drug Administration (“FDA”) Generally Recognized as Safe (“GRAS”) designation at certain doses. Cardax is preparing proprietary nature-identical products and related derivatives … Type: | 0 | 0 | 0 | 17 |
 | BaseClear BaseClear offers genomics expertise and consultancy to accelerate the understanding and use of microorganisms. Microbes have a huge potential to contribute to the solution of a large number of issues facing the modern world, ranging from antibiotic resistance and personal disease to poor crop yields and problems caused by global warming. For years, relatively little was known about the often-invisible world of microbes. However, the latest DNA technologies have provided tools to really see what is happening inside microbes and within microbial communities. This allow us to unravel the interactions between microbes and their hosts and environment. BaseClear, founded in … | 4 | 0 | 4 | 68 |
 | Arrowhead Pharmaceuticals At Arrowhead Pharmaceuticals we are breaking the mold of medicine. We are pushing the boundaries of therapeutic development and revolutionizing how we care for hard-to-treat illnesses. As a company we harness collaboration and innovation to rapidly advance drugs from discovery to the clinic. All applicants: Please be aware of employment scams using Arrowhead’s name and the names of Arrowhead’s employees. All job related Arrowhead communication should come from the domain @arrowheadpharma.com. Biotech, Drug Development, Pharmaceuticals, and RNAi Type: | 3 | 1 | 1 | 556 |
 | Think Research Organizing the world's health knowledge so that everyone gets the best care Think Research is on a mission is to organize the world’s health knowledge so that everyone gets the best care. Our point-of-care, clinical decision support tools are used by health systems and healthcare providers (i.e. doctors, nurses, pharmacists, and more) to dramatically improve healthcare outcomes, save clinicians' time, and reduce administrative burdens and costs. Today, with a growing network of clients, collaborators and partners, this principle of collaboration is supported by our entire suite of applications. Deployed in over 2,200 health care facilities across Canada, the US and … Type: | 0 | 0 | 0 | 155 |
 | Inmunotek Innovating and sharing ideas since 1992 INMUNOTEK is a pharma company which researches, develops, manufactures and distributes therapeutic vaccines in the fields of allergy, infectious diseases and cancer. In addition, the company develops, manufactures and sells medical devices. INMUNOTEK was founded in 1992 with the mission of improving the quality of life of patients and providing value to healthcare professionals, by creating innovative, safe and effective products. INMUNOTEK's products are sold in both Spain and in more than 50 other countries around the world through our subsidiaries, sales offices and exclusive distributors. Our two production centres are based in the … Type: | 3 | 0 | 3 | 327 |
 | The Association of the British Pharmaceutical Industry (ABPI) Medicines and vaccines are transforming our lives like never before. We represent the companies that make them possible. The ABPI exists to make the UK the best place in the world to research, develop and use new medicines. We represent companies of all sizes who invest in discovering the medicines of the future. Our members supply cutting edge treatments that improve and save the lives of millions of people. We work in partnership with Government and the NHS so patients can get new treatments faster and the NHS can plan how much it spends on medicines. Every day, we partner … Type: | 32 | 4 | 24 | 118 |
 | Ambiotis Your partner to resolve inflammation Ambiotis is a pre-clinical CRO specialized in the study of inflammatory processes and the active end of inflammation, called resolution. Resolution is now recognized as the necessary biological process to stop inflammation and restore homeostasis in tissues. This recent approach makes possible to study the inflammation process in a completely innovative and differentiating way. Ambiotis proposes services adapted to pharmaceutical, dermo-cosmetic, agro- food/nutraceutical industries to evaluate the potential of their molecules at preclinical or clinical stages of development. Ambiotis thus helps them to put faster on the market more efficient and innovative compounds on immuno-inflammatory … Type: | 2 | 1 | 1 | 16 |
 | iMiGiNE - PMB With iMiGiNE, the automated PET radiopharmaceutical production system, Personalized Molecular Imaging becomes a reality. PMB-ALCEN has been designing and developing a cutting-edge automated system for the production of radiopharmaceuticals. These are essential in clinical medicine, especially in PET imaging. It combines a superconducting cyclotron with an innovative radiochemistry room, complete with an automated QC system. iMiGiNE is more that just another radiopharmaceutical dispenser. We have envisioned a unique system designed to improve and optimize patient care, while providing new grounds for further research in the nuclear medicine and molecular imaging fields. We offer an alternative to traditional radiopharmaceutical production centers, … Type: | 0 | 0 | 0 | N/A |
 | CHX Challenge Corporate & Charity Fundraising Events in the Alps CHX Challenge design and deliver unique, tailored fundraising & corporate challenges set in extraordinary mountain environments. Focused on hiking mountain trails, winter snowshoeing and accessible alpine summits, no technical experience is necessary. All you need is a love of the outdoors, a level of fitness and a sense of adventure, as well as the enthusiasm to raise money for charity. We escape the crowds to ensure personal challenge, team environment and charitable cause all combine for an unforgettable experience. performance, cultural change, wellbeing, leadership development, team bonding, team building, mental performance, emotional … Type: | 0 | 0 | 0 | 8 |
 | CRCI2NA CRCI2NA Nantes - Angers Cancer and Immunology Research Center The CRCI2NA (Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers in french) was created in January 2022 by the INSERM, the CNRS, the University of Nantes, and the University of Angers as a result of a structuration of oncology and immuno-cancerology research that was initiated in 1979. This Center is composed of 12 research teams dedicated to the analysis of tumors as ecosystems composed of distinct cell types, linked by cooperative or competitive relationships. The overall project of the CRCI2NA is to explore the interactions and dynamic changes of … Type: | 4 | 0 | 2 | 79 |
 | Cancéropôle Grand Ouest [Automatic translation follows] Strengthen and coordinate research and innovation in cancerology @CancéropôleGrandOuest The Cancéropôle Grand Ouest (CGO) aims to generate interregional research centers (Brittany, Centre-Val de Loire, Pays de la Loire) visible on a European scale, capable of developing original and specific cancerology programs in their territory. The CGO brings together teams belonging to major public research organizations (Inserm, CNRS, Ifremer, Inra, CEA, etc.), universities and hospital departments focused on innovation. Through its animation and coordination actions, the CGO team encourages interdisciplinarity, the pooling of skills, the federation and networking of teams, the sharing of technological platforms, and cooperation between … Type: | 9 | 0 | 2 | 12 |
 | SIRIC ILIAD [Automatic translation follows] Integrated Cancer Research Site (SIRIC) SIRIC ILIAD: Integrated Cancer Research Site (SIRIC) | Imaging and Longitudinal Investigations to Ameliorate Decision-making (ILIAD) Within the Nantes – Angers university hospital site, SIRIC ILIAD conducts integrated research of excellence against cancer by combining the expertise of multidisciplinary doctors and researchers (nuclear medicine, oncology, hematology, biological sciences, human and social sciences, epidemiology, chemistry, physics and mathematics) in a logic of decompartmentalization. It brings together the medical, scientific and technological forces: - Cancer care and clinical research teams from 3 health establishments (CHUs and CLCCs). - 30 research teams from 9 laboratories … Type: | 8 | 0 | 3 | 4 |
 | Oncosphère Nouvelle-Aquitaine [Automatic translation follows] The Oncosphère networks all the players involved in cancer research in Nouvelle-Aquitaine. The Oncosphère works to network all the players involved in cancer research in Nouvelle-Aquitaine. It plans to facilitate collaborations between fundamental and translational research teams in biology, epidemiology, public health, science and technology and human and social sciences, from INSERM, CNRS or universities, devoting all or part of their work to the fight against cancer, with start-ups and companies as well as with patient associations and representatives of civil society. The Oncosphère brings together the university campuses of Bordeaux, La Rochelle, Limoges and Poitiers as … Type: | 2 | 1 | 0 | N/A |
 | Center for Infection and Immunity of Lille Infectious diseases are today still leading causes of global mortality and morbidity. One death out of four is due to infections, a proportion just behind cardiovascular diseases and twice as high as mortality due to cancer. This proportion is even higher in children, where infectious diseases are the first cause of death. In addition, the prevalence of chronic inflammatory and auto-immune diseases are on the rise, especially in the industrialized world. Therefore, the Center for Infection and Immunity of Lille is devoted to studying some of the most prevalent infectious disease, such as tuberculosis, malaria, hepatitis C, influenza, schistosomiasis, toxoplasmosis, … Type: | 3 | 0 | 1 | 45 |
 | Pond Biomaterials From nature, back to nature A designer of biomaterials, pond harvest natures own resources and uses advanced technology to create strong and durable biocomposites. pond is a biotech company specialized in making bioresin which has a unique feature – it binds well with naturel fibres. This means the final product is fully biodegradable and ready to be composted when disposed. At pond we are passionate about material awareness and we would like to share this passion with you. Follow us here on LinkedIn and check out our Instagram if you would like to know more about our workday, job openings, … Type: | 4 | 0 | 3 | 6 |
 | M2Bio Sciences, Inc. M2Bio Sciences is a pioneering nutraceutical biotech company. Trading on the OTC: $MRES M2Bio Sciences is a pioneering nutraceutical biotechnology company that delves into the innovative realm of plant-based medicines, healthy food products, and sustainable packaging solutions. A distinctive feature of M2Bio Sciences is its divisional structure, each focusing on a specific wellness and sustainability aspect. It is committed to improving both human health and the planet's health. Ethically and sustainably sourced products are central to its mission, reflecting a deep-rooted concern for environmental sustainability. The Company employs cutting-edge artificial intelligence to power its endeavours. Medicine, Biotechnology, Health , Neuroscience, … Type: | 5 | 1 | 1 | 14 |
 | Astellas Gene Therapies Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina. Content is intended for a US audience. gene therapy and biotechnology Type: | 3 | 0 | 2 | 403 |
 | Labcorp Drug Development In Pursuit of Answers Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers. With unparalleled diagnostics and drug development capabilities, we accelerate innovation and provide insight to improve health and improve lives. Whether you’re a patient, provider, researcher or in the pharmaceutical industry, we’re here for you. More than 70,000 employees strong, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY 2020. Learn more at www.Labcorp.com Drug Development Services , Toxicology Services, Central Labs, Central Laboratory Services , Clinical Trial Management , CRO … Type: | 5 | 1 | 3 | 9,363 |
 | NeuroTeam Srl NeuroTeam SRL is a startup company, formerly a University of Palermo spin-off, focussing on cognitive diseases. The team is composed of neuropsychologists, clinical psychologists, psychotherapists, neurologists and neurophysiologists, with many years experience in the field of scientific research and clinical disorders of neurological and mental sphere. NeuroTeam services provide an integrated, neurological and psychological, for the diagnosis and treatment of mental suffering. Our specificity is to treat the neurological and mental patient with a non-invasive neuro-modulation approach. This unique treatment is a result of scientific experience gained on more than twenty years within universities and research centers, at national and … Type: | 1 | 0 | 0 | 11 |
 | HALLURA when beauty meets science Breaking with 20-year-old technologies and answering the growing demand for natural and soft aesthetic treatments, HALLURA is reinventing Hyaluronic Acid Dermal Fillers Type: | 0 | 0 | 0 | 15 |
 | Fount Bio, Inc. A life science company developing innovative technologies to enhance the health and beauty of your skin Fount Bio is applying proprietary advances in glycopolymer research to become the world’s first platform for building a long-lasting hyaluronic acid network within the skin via topical application. Fount’s Flī-HATM technology overcomes both the delivery and biostability challenges of current forms of HA, that until now, have prevented the development of products that fully unleash HA’s benefits without the need for invasive injections. Type: | 1 | 1 | 0 | 11 |
 | Elsa Science A patient-centered, digital solution designed to manage rheumatic conditions through self-care and remote monitoring. Elsa Science strives to contribute to a future where chronic disease is minimized. Where people who are diagnosed can reach optimal health sooner and live a new life faster, and to its full potential. Elsa Science was established in 2017 by a team of influential scientists and award winning designers who have a passion to improve the health of people living with chronic disease. Driven by science, self-reported patient data, and individualized care, and through meaningful content and design, Elsa Science aims to make science accessible … Type: | 1 | 0 | 1 | 22 |
 | Devicare The Digital Therapeutic Company in Urology Devicare is a specialty biotech company dedicated to develop pathbreaking medical treatments in Urology combining the most recent scientific advances in nutritional therapy with digital technologies. Biotechnology, Medical devices , Digital Health , eHealth, Healthcare, and Digital Therapeutics Type: | 7 | 0 | 4 | 24 |
 | Optellum Early lung cancer diagnosis with AI Optellum was founded so that every lung cancer patient is treated at the earliest possible stage, and cured. We are redefining early interception of lung disease, by enabling every clinician, in every hospital, to manage their patients in the optimal way. Our first product is the first Clinical Decision Support software for personalized early diagnosis & treatment of lung cancer, based on Artificial Intelligence & Machine Learning applied to the world’s largest clinical dataset. We are a team of world-leading medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision … Type: | 5 | 1 | 2 | 49 |
 | Peptone Drugging disordered proteins with physics and AI Peptone is a therapeutics company that uses AI and an experimental physics product engine to design small molecules targeting the 6,200 intrinsically disordered human proteins that Alpha Fold 3 cannot model. artificial intelligence, structural biology, high performance computing, supercomputers, biotechnology, and intrinsically disordered proteins Type: | 46 | 4 | 46 | 40 |
 | Kalderos The drug discount platform designed for everyone. Kalderos delivers technology that solves the challenges facing the US healthcare system. We work with healthcare providers, drug manufacturers, payers, and government agencies alike to increase transparency and restore trust — lowering the cost of healthcare and enabling everyone to focus on improving the health of people. Technology, Healthcare, Pharmacuticals, 340B Drug Discount Program, Medicaid, Rebates, PBM, Discounts, Drug Pricing, Data Infrastructure, Analytics, MDRP, and CMC Type: | 2 | 0 | 2 | 132 |
 | Neurocern Connecting clinical and financial data, an artificial intelligence engine that transforms data into actionable insights Neurocern is a minority female physician-founded, and veteran-owned AI and neuroinformatics company. Neurocern’s AI platform ingests data from previously siloed sources — including electronic health records, prescription data, insurance claims data, and more — to uncover insights that drive health outcomes, enterprise performance, and financial ROI for health systems, insurers, and life sciences companies. Predictive Analytics, Dementia, Clinical Decision Support, Alzheimer's Disease, Parkinson's Disease, informatics, Artificial Intelligence, Prescriptive Analytics, and Stroke Type: | 8 | 2 | 7 | 1 |
 | Desktop Genetics Powering the genome editing revolution with AI-driven design and analysis for cell therapy and drug discovery. Desktop Genetics is an international company established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology. We have invested four years developing our core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers our flagship DESKGEN CRISPR Library … Type: | 2 | 1 | 0 | 0 |
 | Ultimaxx Health Changing The World Naturally At Ultimaxx Health we have made it our mission to develop innovative solutions to pressing public health problems and Natural products that will improve the general health and well being of consumers. Our initial US Patented product is a safe, effective, clinically tested non-narcotic OTC pain relief alternative (tablet form), marketed under the trade name LEVARE® (la-var-ay). LEVARE was developed to help mitigate the epidemic of prescription narcotic "painkiller" abuse in the U.S. The U.S. comprises 5% of the world's population and consumes 80% of it's prescription narcotics. Because of this excessive consumption, the U.S. is … Type: | 1 | 1 | 1 | 7 |
 | Surface Oncology Inc. #lifeunderthesurface #BBJBestPlacesToWork2023,2022,2021 #BostonGlobeTopPlacesToWork2023,2022,2021 Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies … Type: | 2 | 1 | 0 | 14 |
 | NimbleRx Building the largest, MOST loved pharmacy technology platform for prescriptions in America. Nimble is a health technology company that enables people to live their best lives. We do this by empowering local and national pharmacies and in turn improve access to medications for customers. We started by getting medications to those who need them, but we envision a world where managing your health is easier and leads to happier, fuller lives and thriving local businesses. Healthcare, Pharmacy, Delivery, Prescription, Mobile, Technology, Internet, and SaaS Type: | 2 | 0 | 0 | 152 |
 | Emedgene, an Illumina Company Unlock genomic insights Emedgene is on a mission to unlock genomic insights for the world’s health organizations by providing data-driven AI solutions for genomic diagnostics and discovery at scale. We work with leading healthcare and life sciences organizations to enable precision medicine programs, enable high throughput diagnostics and accelerate the pace of research. Genomics, Human Genetics, Big Data, and Algorithms Type: | 3 | 2 | 2 | 14 |
 | Agios Pharmaceuticals Where science meets heart. Passionately committed to transforming the lives of people with genetically defined diseases. Agios is a biopharmaceutical company that is fueled by connections. We are passionately committed to applying our leadership in the field of cellular metabolism to create life-changing therapies for people living with rare diseases. The bonds we build with patient communities, healthcare professionals, partners and colleagues help elevate our thinking and propel our science to new heights. These connections, combined with our cellular metabolism expertise, have fueled the development and approval of our first-in-class pyruvate kinase (PK) activator, as well as other investigational therapies. … Type: | 8 | 2 | 3 | 587 |
Startup